Saı̈d Kamel

6.5k total citations
132 papers, 4.6k citations indexed

About

Saı̈d Kamel is a scholar working on Nephrology, Molecular Biology and Oncology. According to data from OpenAlex, Saı̈d Kamel has authored 132 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Nephrology, 41 papers in Molecular Biology and 32 papers in Oncology. Recurrent topics in Saı̈d Kamel's work include Parathyroid Disorders and Treatments (37 papers), Bone health and treatments (27 papers) and Bone Metabolism and Diseases (21 papers). Saı̈d Kamel is often cited by papers focused on Parathyroid Disorders and Treatments (37 papers), Bone health and treatments (27 papers) and Bone Metabolism and Diseases (21 papers). Saı̈d Kamel collaborates with scholars based in France, United States and Belgium. Saı̈d Kamel's co-authors include Michel Brazier, Romuald Mentaverri, Ziad A. Massy, Alice Wattel, Michel Brazier, Florence Lorget, Lucie Hénaut, Cédric Boudot, M. Maamer and Laurent Petit and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Saı̈d Kamel

128 papers receiving 4.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Saı̈d Kamel France 41 1.5k 1.1k 804 749 735 132 4.6k
Lars Melholt Rasmussen Denmark 47 2.9k 2.0× 932 0.8× 892 1.1× 486 0.6× 596 0.8× 288 8.2k
Xiaoping Xing China 29 1.0k 0.7× 948 0.9× 999 1.2× 449 0.6× 678 0.9× 298 3.8k
Katsuhito Mori Japan 36 1.2k 0.8× 2.4k 2.2× 478 0.6× 573 0.8× 450 0.6× 172 5.9k
Pascal Houillier France 42 2.2k 1.5× 3.0k 2.7× 426 0.5× 710 0.9× 411 0.6× 169 6.6k
Hirotoshi Morii Japan 37 1.3k 0.8× 2.2k 2.0× 748 0.9× 770 1.0× 788 1.1× 169 5.8k
Mary F. Burritt United States 35 1.2k 0.8× 611 0.6× 446 0.6× 369 0.5× 474 0.6× 71 3.7k
Hideyuki Yamato Japan 27 677 0.5× 1.0k 0.9× 397 0.5× 396 0.5× 442 0.6× 74 2.4k
Jung‐Min Koh South Korea 37 1.7k 1.1× 216 0.2× 858 1.1× 302 0.4× 1.5k 2.0× 186 4.7k
Carol C. Pilbeam United States 42 2.3k 1.6× 214 0.2× 1.6k 2.0× 510 0.7× 1.0k 1.4× 110 5.4k
Takahiro Yasui Japan 37 1.5k 1.0× 726 0.7× 551 0.7× 357 0.5× 85 0.1× 394 5.5k

Countries citing papers authored by Saı̈d Kamel

Since Specialization
Citations

This map shows the geographic impact of Saı̈d Kamel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saı̈d Kamel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saı̈d Kamel more than expected).

Fields of papers citing papers by Saı̈d Kamel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saı̈d Kamel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saı̈d Kamel. The network helps show where Saı̈d Kamel may publish in the future.

Co-authorship network of co-authors of Saı̈d Kamel

This figure shows the co-authorship network connecting the top 25 collaborators of Saı̈d Kamel. A scholar is included among the top collaborators of Saı̈d Kamel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saı̈d Kamel. Saı̈d Kamel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Louvet, Loı̈c, et al.. (2025). Macrophages as key modulators of calcific aortic valve disease. Frontiers in Cardiovascular Medicine. 12. 1664067–1664067.
2.
Kamel, Saı̈d, Natália Alencar de Pinho, Nicolas Mansencal, et al.. (2024). Ionized and total magnesium levels in patients with chronic kidney disease: associated factors and outcomes. Clinical Kidney Journal. 17(4). sfae046–sfae046. 2 indexed citations
3.
Bohbot, Yohann, Agnès Pasquet, Momar Diouf, et al.. (2023). Chronic kidney disease is a key risk factor for aortic stenosis progression. Nephrology Dialysis Transplantation. 38(12). 2776–2785. 11 indexed citations
4.
5.
Abou‐Arab, Osama, Saı̈d Kamel, Stéphane Bar, et al.. (2021). Changes in Plasma Angiopoietin Levels After Transcatheter Aortic Valve Replacement and Surgical Aortic Valve Replacement: A Prospective Cohort Study. Journal of Cardiothoracic and Vascular Anesthesia. 35(11). 3215–3222.
6.
Mentaverri, Romuald, Thomas Duflot, Gilles Kauffenstein, et al.. (2020). The Metabolism of Epoxyeicosatrienoic Acids by Soluble Epoxide Hydrolase Is Protective against the Development of Vascular Calcification. International Journal of Molecular Sciences. 21(12). 4313–4313. 8 indexed citations
7.
Kamel, Saı̈d, et al.. (2020). Effects of Chronic Kidney Disease and Uremic Toxins on Extracellular Vesicle Biology. Toxins. 12(12). 811–811. 13 indexed citations
8.
Kamel, Saı̈d, et al.. (2019). Insights on glycated albumin. Annales de biologie clinique. 77(4). 407–414. 3 indexed citations
9.
Tribouilloy, Christophe, Dan Ruşinaru, Sylvestre Maréchaux, et al.. (2015). Low-Gradient, Low-Flow Severe Aortic Stenosis With Preserved Left Ventricular Ejection Fraction. Journal of the American College of Cardiology. 65(1). 55–66. 116 indexed citations
10.
Paccou, Julien, Michel Brazier, Romuald Mentaverri, et al.. (2012). Vascular calcification in rheumatoid arthritis: Prevalence, pathophysiological aspects and potential targets. Atherosclerosis. 224(2). 283–290. 22 indexed citations
11.
Chasseraud, Maud, et al.. (2011). Tumor Necrosis Factor‐Related Apoptosis‐Inducing Ligand and Vascular Calcification. Therapeutic Apheresis and Dialysis. 15(2). 140–146. 18 indexed citations
12.
Ivanovski, Ognen, Igor Nikolov, Nobuhiko Joki, et al.. (2008). The calcimimetic R-568 retards uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE−/−) mice. Atherosclerosis. 205(1). 55–62. 93 indexed citations
13.
Mentaverri, Romuald, et al.. (2008). Multiple myeloma cells directly stimulate bone resorption in vitro by down-regulating mature osteoclast apoptosis. Leukemia Research. 32(8). 1279–1287. 16 indexed citations
14.
Duplat, Denis, Anne Chabadel, Marlène Gallet, et al.. (2007). The in vitro osteoclastic degradation of nacre. Biomaterials. 28(12). 2155–2162. 43 indexed citations
15.
Wattel, Alice, Saı̈d Kamel, Jean‐Pierre Petit, et al.. (2004). Flavonoid quercetin decreases osteoclastic differentiation induced by RANKL via a mechanism involving NFκB and AP‐1. Journal of Cellular Biochemistry. 92(2). 285–295. 158 indexed citations
16.
Gallet, Marlène, Nicolas Sévenet, Claude Dupont, Michel Brazier, & Saı̈d Kamel. (2004). Breast cancer cell line MDA-MB 231 exerts a potent and direct anti-apoptotic effect on mature osteoclasts. Biochemical and Biophysical Research Communications. 319(2). 690–696. 14 indexed citations
17.
Lorget, Florence, Romuald Mentaverri, B. Meddah, et al.. (2000). Evaluation of in Vitro Bone Resorption: High-Performance Liquid Chromatography Measurement of the Pyridinolines Released in Osteoclast Cultures. Analytical Biochemistry. 284(2). 375–381. 8 indexed citations
18.
Mentaverri, Romuald, Florence Lorget, Alice Wattel, et al.. (2000). Régulation ostéoblastique de la survie des ostéoclastes : effets du calcitriol. Comptes Rendus de l Académie des Sciences - Series III - Sciences de la Vie. 323(11). 951–957.
19.
Fardellone, Patrice, et al.. (1998). Biochemical effects of calcium supplementation in postmenopausal women: influence of dietary calcium intake. American Journal of Clinical Nutrition. 67(6). 1273–1278. 57 indexed citations
20.
Castelain, Sandrine, Saı̈d Kamel, Christine J. Picard, et al.. (1995). A simple and automated HPLC method for determination of total hydroxyproline in urine. Comparison with excretion of pyridinolines. Clinica Chimica Acta. 235(1). 81–90. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lars Melholt Rasmussen Breakdown of academic impact, for papers by Xiaoping Xing Breakdown of academic impact, for papers by Katsuhito Mori Breakdown of academic impact, for papers by Pascal Houillier Breakdown of academic impact, for papers by Hirotoshi Morii Breakdown of academic impact, for papers by Mary F. Burritt Breakdown of academic impact, for papers by Hideyuki Yamato Breakdown of academic impact, for papers by Jung‐Min Koh Breakdown of academic impact, for papers by Carol C. Pilbeam Breakdown of academic impact, for papers by Takahiro Yasui
Rankless by CCL
2026